Import Safety Agreement Further Entwines FDA/China Regulatory Process
This article was originally published in PharmAsia News
Executive Summary
Chinese manufacturers of certain drugs or active pharmaceutical ingredients selected by FDA will have to meet new registration standards as part of a memorandum of understanding signed Dec. 11 in Beijing by HHS, FDA and China's State Food and Drug Administration
You may also be interested in...
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
WASHINGTON, D.C. - In introducing China President Hu Jintao at a luncheon reception Jan. 20, former Secretary of State Henry Kissinger said that if China and the U.S. work together most of the problems between the two nations "will find a creative solution," but if the two nations can't do that, then "there is no possibility for one side or the other achieving a success over the other.
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
WASHINGTON, D.C. - In introducing China President Hu Jintao at a luncheon reception Jan. 20, former Secretary of State Henry Kissinger said that if China and the U.S. work together most of the problems between the two nations "will find a creative solution," but if the two nations can't do that, then "there is no possibility for one side or the other achieving a success over the other.
Chinese President Pledges China Will Not Discriminate Against U.S. Businesses; Broad Healthcare Partnership Unveiled
The public-private partnership includes Pfizer, Johnson & Johnson, Abbott, Medtronic, General Electric, Chindex and Microsoft.